CN114507613B - Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof - Google Patents
Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof Download PDFInfo
- Publication number
- CN114507613B CN114507613B CN202210093958.4A CN202210093958A CN114507613B CN 114507613 B CN114507613 B CN 114507613B CN 202210093958 A CN202210093958 A CN 202210093958A CN 114507613 B CN114507613 B CN 114507613B
- Authority
- CN
- China
- Prior art keywords
- santalene
- coding gene
- fermentation
- strain
- synthase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 42
- 230000004151 fermentation Effects 0.000 title claims abstract description 42
- KWFJIXPIFLVMPM-KHMAMNHCSA-N (+)-alpha-santalene Chemical compound CC(C)=CCC[C@]1(C)[C@@H]2C[C@H]3[C@@H](C2)[C@@]13C KWFJIXPIFLVMPM-KHMAMNHCSA-N 0.000 title claims abstract description 39
- KWFJIXPIFLVMPM-BSMMKNRVSA-N alpha-santalene Natural products C(=C\CC[C@]1(C)C2(C)[C@H]3[C@@H]2CC1C3)(\C)/C KWFJIXPIFLVMPM-BSMMKNRVSA-N 0.000 title claims abstract description 39
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 31
- 241000894006 Bacteria Species 0.000 title claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 101
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 29
- 238000010276 construction Methods 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 23
- 101710194655 Santalene synthase Proteins 0.000 claims description 23
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims description 22
- 101001081533 Homo sapiens Isopentenyl-diphosphate Delta-isomerase 1 Proteins 0.000 claims description 14
- 102100027665 Isopentenyl-diphosphate Delta-isomerase 1 Human genes 0.000 claims description 13
- 108010065958 Isopentenyl-diphosphate Delta-isomerase Proteins 0.000 claims description 12
- 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 claims description 11
- 101710089428 Farnesyl pyrophosphate synthase erg20 Proteins 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 101150084072 ERG20 gene Proteins 0.000 claims description 6
- 241001506991 Komagataella phaffii GS115 Species 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 108091033409 CRISPR Proteins 0.000 claims description 3
- 102100037458 Dephospho-CoA kinase Human genes 0.000 claims description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 3
- 229940094933 n-dodecane Drugs 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 2
- 102000013404 Geranyltranstransferase Human genes 0.000 claims description 2
- 108010026318 Geranyltranstransferase Proteins 0.000 claims description 2
- 101000952691 Homo sapiens Dephospho-CoA kinase Proteins 0.000 claims description 2
- 229940100228 acetyl coenzyme a Drugs 0.000 claims description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 20
- 108090000790 Enzymes Proteins 0.000 abstract description 20
- 230000014509 gene expression Effects 0.000 abstract description 13
- 230000002503 metabolic effect Effects 0.000 abstract description 5
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 230000004907 flux Effects 0.000 abstract description 3
- 230000037353 metabolic pathway Effects 0.000 abstract description 3
- 230000006696 biosynthetic metabolic pathway Effects 0.000 abstract description 2
- 239000002243 precursor Substances 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 46
- 239000013612 plasmid Substances 0.000 description 44
- 239000013598 vector Substances 0.000 description 40
- 229930013258 santalene Natural products 0.000 description 25
- KWFJIXPIFLVMPM-UHFFFAOYSA-N α-santalene Chemical compound C1C2C3(C)C2CC1C3(C)CCC=C(C)C KWFJIXPIFLVMPM-UHFFFAOYSA-N 0.000 description 25
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 16
- 239000012634 fragment Substances 0.000 description 14
- 235000008632 Santalum album Nutrition 0.000 description 12
- 238000003259 recombinant expression Methods 0.000 description 12
- 241000221035 Santalaceae Species 0.000 description 11
- 239000013604 expression vector Substances 0.000 description 10
- 241000235648 Pichia Species 0.000 description 9
- 238000005520 cutting process Methods 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 108020005004 Guide RNA Proteins 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 2
- 240000000513 Santalum album Species 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- PGBNIHXXFQBCPU-ILXRZTDVSA-N (-)-beta-santalene Chemical class C1C[C@H]2C(=C)[C@@](CCC=C(C)C)(C)[C@@H]1C2 PGBNIHXXFQBCPU-ILXRZTDVSA-N 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000008016 Eukaryotic Initiation Factor-3 Human genes 0.000 description 1
- 108010089790 Eukaryotic Initiation Factor-3 Proteins 0.000 description 1
- 108050002021 Integrator complex subunit 2 Proteins 0.000 description 1
- 102100033265 Integrator complex subunit 2 Human genes 0.000 description 1
- 101100326526 Komagataella phaffii (strain GS115 / ATCC 20864) PAS_chr4_0465 gene Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 101000767160 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Intracellular protein transport protein USO1 Proteins 0.000 description 1
- 229930192650 Santalin Natural products 0.000 description 1
- 235000008631 Santalum Nutrition 0.000 description 1
- 241001496113 Santalum Species 0.000 description 1
- XWQLUVQFUZQPDY-UHFFFAOYSA-N Sesquifenchene Chemical class CC(=CCCC1(C)C2CCC1C(=C)C2)C XWQLUVQFUZQPDY-UHFFFAOYSA-N 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 108010083912 bleomycin N-acetyltransferase Proteins 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 108010049285 dephospho-CoA kinase Proteins 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000010671 sandalwood oil Substances 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- -1 sesquiterpene compound Chemical class 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01034—Hydroxymethylglutaryl-CoA reductase (NADPH) (1.1.1.34)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/0101—(2E,6E)-Farnesyl diphosphate synthase (2.5.1.10), i.e. geranyltranstransferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
- C12Y402/03082—Alpha-santalene synthase (4.2.3.82)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/03—Intramolecular oxidoreductases (5.3) transposing C=C bonds (5.3.3)
- C12Y503/03002—Isopentenyl-diphosphate DELTA-isomerase (5.3.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
- C12Y602/01—Acid-Thiol Ligases (6.2.1)
- C12Y602/01001—Acetate-CoA ligase (6.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/102—Plasmid DNA for yeast
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a yeast engineering bacterium for producing alpha-santalene by fermentation and application thereof, belonging to the field of bioengineering. The yeast is taken as an original strain, and the yeast engineering bacteria for producing the alpha-santalene through fermentation are obtained through the construction of introduced genes. The yeast engineering bacteria can efficiently produce the alpha-santalene, the shake flask fermentation yield is approximately 3.0g/L, and the fermentation yield of a 1L fermentation tank can reach 15g/L. The metabolic flux in the biosynthesis pathway of the alpha-santalene is improved by high expression of key speed-limiting enzymes in the metabolic pathway, enhancement of precursor supply and a multi-copy strategy, and the alpha-santalene is efficiently generated by using pichia pastoris, so that the method has the characteristics of short period, environmental protection and resource conservation. The yeast engineering strain for high-yield alpha-santalene has wide application prospect.
Description
Technical Field
The invention relates to the field of bioengineering, in particular to a yeast engineering bacterium for producing alpha-santalene by fermentation and application thereof.
Background
Santalene with molecular formula of C 15 H 24 Belongs to a bicyclo sesquiterpene compound. There are two isomers of α -santalene and β -santalene. The alpha-santalene has a boiling point of 252 ℃ (100.39 kPa) and is present in the santalin volatile oil. Alpha-santalene as santalum albumOne of the main components of the essential oil has lasting fragrance, is widely applied to the industries of essence and spice, has pharmacological activities of antibiosis, antioxidation, anti-tumor and the like, and can be used as a rare health care medicine.
The natural sandalwood oil is mainly from the heart wood part of the sandalwood, natural sandalwood essential oil is prepared by extraction means such as organic reagent extraction, distillation and the like, and the extraction amount of the essential oil is different by mainly using a steam distillation method, an diethyl ether impregnation method, a solvent reflux method and the like. The components of the sandalwood essential oil are greatly different due to different production places and varieties of the sandalwood, and the aroma effect is inconsistent, so that the standard of the sandalwood essential oil cannot be controlled. In addition, due to the special growth characteristics of the sandalwood and the problem of long core maturation period, natural sandalwood resources are gradually exhausted.
Along with the continuous improvement of the human living standard, the demand for sandalwood products is also continuously increased, the early natural sandalwood resources are used up by unreasonable felling of human beings, the update time of the natural sandalwood forest is as long as 30 years or longer, and the factors enable the price of the valuable tree species of the sandalwood to be increased, so that the increasingly-growing market demand cannot be met.
The bioconversion method has no limitation of various conditions and is environment-friendly, and in recent years, with the development of synthetic biology technology, if the microbial cell factory is adopted for heterologous biosynthesis of santalene, the efficiency can be improved, the cost can be reduced, the limitation of natural conditions can be broken, and the contradiction between supply and demand of santalum album essential oil can be effectively relieved.
At present, a literature reports key genes for synthesizing alpha-santalene from santalum album plants, which lays a good foundation for synthesizing the alpha-santalene in a heterologous way. With the development of synthetic biology, many natural products can be expressed in pichia pastoris, like terpenes, flavonoids, etc. Pichia pastoris is taken as a recognized safe strain, and genetic background, metabolic pathways and regulation mechanisms of the Pichia pastoris have been well known for many years. Meanwhile, pichia pastoris is eukaryotic, has high growth speed, high environmental tolerance, simple fermentation conditions and the like, and can be widely used as ideal host bacteria for expressing heterologous proteins and producing bio-based compounds.
Although santalene has a plurality of application prospects, the low yield of santalene currently limits the application of santalene in different fields. The synthesis of plant-derived natural products by microorganisms is a very environment-friendly and efficient way, and no related report on production of santalene by pichia pastoris cell factories exists at present.
Disclosure of Invention
In order to solve the defects in the prior art, the invention provides a yeast engineering bacterium for producing alpha-santalene by fermentation and application thereof.
The yeast engineering strain is obtained by firstly utilizing a gene editing technology to highly express a santalene synthase SAS, secondly, removing the speed limiting step of a mevalonate pathway by highly expressing 3-hydroxy-3-methylglutaryl-CoA reductase 1tHMG1, and then improving the metabolic flux by using a high expression pathway speed limiting enzyme isopentenyl pyrophosphate isomerase IDI1 and a farnesyl pyrophosphate synthase ERG20, then highly expressing an acetyl-CoA synthase ACS and finally increasing the SAS copy number.
The invention provides a yeast engineering bacterium for producing alpha-santalene by fermentation, which is obtained by taking yeast as an original strain and constructing an introduced gene, wherein the introduced gene comprises any one of the following groups:
(1) A coding gene of santalene synthase SAS, a coding gene of 3-hydroxy-3-methylglutaryl-CoA reductase 1tHMG1, a coding gene of isopentenyl pyrophosphate isomerase IDI1, a coding gene of farnesyl pyrophosphate synthase ERG20 and a coding gene of acetyl-CoA synthase ACS;
(2) A coding gene of santalene synthase SAS;
(3) A coding gene of a santalene synthase SAS, a coding gene of 3-hydroxy-3-methylglutaryl coenzyme A reductase 1tHMG1, a coding gene of isopentenyl pyrophosphate isomerase IDI1 and a coding gene of farnesyl pyrophosphate synthase ERG 20.
Preferably, the coding gene of the santalene synthase SAS in the introduced gene is 1 or more copies.
More preferably, the coding gene of the santalene synthase SAS in the introduced gene is 1-3 copies.
Preferably, the starting strain is pichia pastoris, saccharomyces cerevisiae or yarrowia lipolytica.
More preferably, the starting strain is pichia pastoris, for example pichia pastoris GS115 strain.
The coding gene of the santalene synthase SAS is shown as SEQ ID NO.1, the coding gene of 3-hydroxy-3-methylglutaryl coenzyme A reductase 1tHMG1 is shown as SEQ ID NO.2, the coding gene of isopentenyl pyrophosphate isomerase IDI1 is shown as SEQ ID NO.3, the coding gene of farnesyl pyrophosphate synthase ERG20 is shown as SEQ ID NO.4, and the coding gene of acetyl coenzyme A synthase ACS is shown as SEQ ID NO. 5.
The invention also provides a construction method of the yeast engineering bacteria for producing alpha-santalene by fermentation, wherein the introduced genes comprise coding genes of santalene synthase SAS, 3-hydroxy-3-methylglutaryl-CoA reductase 1tHMG1, coding genes of isopentenyl pyrophosphate isomerase IDI1, coding genes of farnesyl pyrophosphate synthase ERG20 and coding genes of acetyl CoA synthase ACS, and the construction method comprises the following steps:
(1) Integrating a coding gene sequence of a santalene synthase SAS into a genome of Pichia pastoris GS115-Cas9 (obtained by introducing a Pichia pastoris GS115 strain genome into a Cas9 protein coding gene), so as to obtain a strain Pa-1;
(2) Integrating the coding gene sequence of 3-hydroxy-3-methylglutaryl coenzyme A reductase 1tHMG1, the coding gene sequence of isopentenyl pyrophosphate isomerase IDI1 and the coding gene sequence of farnesyl pyrophosphate synthetase ERG20 into a strain Pa-1 to obtain a strain Pa-2;
(3) Integrating the coding gene sequence of acetyl-CoA synthase ACS into the strain Pa-2 to obtain a strain Pa-3;
(4) 2 coding gene sequences of single copy santalene synthase SAS are integrated into a strain Pa-3 to obtain a strain Pa-4, namely the yeast engineering bacteria for producing alpha-santalene by fermentation.
The promoter used in the construction process is pTEF or pGAP, the nucleotide sequence of the promoter pTEF is shown in SEQ ID NO.6, and the nucleotide sequence of the promoter pGAP is shown in SEQ ID NO. 7; the terminator is tAOX1, and the nucleotide sequence is shown in SEQ ID NO. 8.
The invention also provides application of the yeast engineering bacteria for producing alpha-santalene by fermentation in preparation of the alpha-santalene.
The invention also provides a method for preparing the alpha-santalene, which comprises the steps of fermenting and culturing the yeast engineering bacteria for producing the alpha-santalene by fermentation, and extracting to obtain the alpha-santalene.
The specific fermentation culture method comprises the following steps: the yeast engineering bacteria are inoculated in 50mL YPD culture medium according to the inoculation amount of 1-5 percent by volume percent, and are fermented for 5 days at 30 ℃ and 250rpm, and 2 percent of glucose is added every 24 hours.
Compared with the prior art, the invention has the following advantages:
(1) The yeast engineering bacteria can efficiently produce the alpha-santalene, the shake flask fermentation yield is approximately 3.0g/L, and the fermentation yield of a 1L fermentation tank can reach 15g/L.
(2) The invention improves the metabolic flux in the alpha-santalene biosynthesis pathway by highly expressing key rate-limiting enzymes in the metabolic pathway, enhancing precursor supply and multicopy strategy.
(3) The invention utilizes pichia pastoris to efficiently generate the alpha-santalene, and has the characteristics of short period, environmental protection and resource conservation. The yeast engineering strain for high-yield alpha-santalene has wide application prospect.
Drawings
FIG. 1 is a metabolic scheme for the biosynthesis of santalene.
FIG. 2 is a schematic diagram of a pathway modification key enzyme expression cassette.
FIG. 3 is a map of plasmid Int-pTEF-BamHI-tAOX 1.
FIG. 4 is a map of plasmid Int-pGAP-AatII-tAOX 1.
FIG. 5 is a map of plasmid HZP-sgRNA.
FIG. 6 is a map of plasmid HHP-sgRNA.
FIG. 7 is a map of plasmid HGP-sgRNA.
FIG. 8 is a graph of GC-MS detection mass spectrum ion response values of santalene.
FIG. 9 is a graph showing the comparison of the yields of shake flask cultures of different strains in example 5.
FIG. 10 is a GC-MS detection mass spectrum of santalene.
Detailed Description
The metabolic flow chart of the biosynthesis of santalene is shown in figure 1, the pathway modification key enzyme expression cassette is shown in figure 2, and the detailed synthesis pathway is shown in the examples.
Example 1: construction of Pichia santalene recombinant strain Pa-1
The Int refers to the insertion site of Pichia pastoris GS115 genome, and the auxiliary plasmid Int-pTEF-tAOX1, int-pGAP-tAOX1 used consists of a general skeleton (an ampicillin resistance gene expression cassette plus a replication initiation site ori of a prokaryotic gene plasmid), a 500bp homology arm at the upstream and downstream of the site, pTEF-BamHI-tAOX1 or pGAP-Aat II-tAOX 1 (a plasmid map is shown in figures 3 and 4); helper plasmids HZP-sgRNA, HHP-sgRNA and HGP-sgRNA consist of a general framework, a resistance gene expression cassette, a sgRNA with a corresponding site and a BsaI cleavage site, and Z, H, G respectively represent a bleomycin resistance gene, a hygromycin resistance gene and a G418 resistance gene (plasmid maps are shown in FIG. 5, FIG. 6 and FIG. 7); p is plasmid (plasmid).
Starting from auxiliary plasmid Int2-pTEF-tAOX1 (stored in a laboratory, the left gene PAS_chr1-3_0003 of Int2 and the right gene PAS_chr1-3_0004), introducing a santalene synthase coding gene SAS (shown as SEQ ID NO. 1) by using enzyme cutting site BamHI in the vector to obtain a recombinant vector Int2-pTEF-SAS-tAOX1; starting from helper plasmid HZP-sgRNA (stored in a laboratory), the sgRNA-Int2 is introduced by using enzyme cutting site BsaI in the vector to obtain recombinant vector HZP-sgRNA-Int2. Then, a donor primer is designed by taking a recombinant vector Int2-pTEF-SAS-tAOX1 as a template, PCR is carried out to obtain a corresponding Int2-donor, the corresponding Int2-donor and a corresponding recombinant guide plasmid HZP-sgRNA-Int2 are transformed into a pichia pastoris cell GS115-Cas9 (obtained by introducing a Cas9 protein coding gene into a pichia pastoris GS115 strain genome), and the recombinant strain Pa-1 is obtained, and the specific implementation is as follows:
(1) Construction of santalene synthase recombinant expression vector
The coding gene of the santalene synthase SAS is synthesized by the Kirsrui biotechnology Co-Ltd, a primer SAS-F/SAS-R is designed to amplify a target gene SAS by taking the santalene synthase gene SAS as a template, and the target gene SAS is assembled with a vector Int2-pTEF-tAOX1 after enzyme digestion by using a seamless cloning method and is transformed into an escherichia coli DH5 alpha strain so as to obtain a recombinant vector Int2-pTEF-SAS-tAOX1.
The primer sequences used were as follows:
SAS-F:atacattttagttattcgccaacGatgtctactcaacaagtttcttctg;
SAS-R:CAAATGGCATTCTGACATCCTCTTGAGttagtcgtccaacttaactggg。
(2) Construction of vector HZP-sgRNA-Int2 for recombinant expression of guide RNA
The plasmid HZP-sgRNA is used as a template (the plasmid map is shown in figure 5), primers Int2-sgRNA-F and Int2-sgRNA-R are designed, the Int2-sgRNA is introduced by using enzyme cutting sites BsaI in the vector HZP-sgRNA, and the recombinant vector HZP-sgRNA-Int2 is obtained through T4 enzyme connection.
The primer sequences used were as follows:
Int2-sgRNA-F:acgctcacggattcaggaaatacg;
Int2-sgRNA-R:AAACcgtatttcctgaatccgtga。
(3) Transformation of Pichia santalene recombinant strain Pa-1
The recombinant vector Int2-pTEF-SAS-tAOX1 is used as a template to design primers Int2-donor-F and Int2-donor-R, PCR is carried out to obtain a corresponding linearized fragment Int2-donor, and the linearized fragment Int2-donor and a corresponding recombinant guide plasmid HZP-sgRNA-Int2 are simultaneously transformed into Pichia pastoris cells GS115-Cas9 to obtain the recombinant strain Pa-1. The resistant plasmid was discarded at the same time as passaging several times.
The primer sequences used were as follows:
Int2-donor-F:agaaggcaaagaatcttctgac;Int2-donor-R:taggctaaaccaagtgatttttc。
example 2: construction of Pichia santalene recombinant strain Pa-2
Respectively constructing expression cassettes of high expression genes tHMG1, IDI1 and ERG20 and corresponding guide plasmids, sequentially transferring the expression cassettes into the recombinant strain Pa-1, and respectively obtaining pichia pastoris recombinant strains Pa-1, pa-1-2 and Pa-2 through round-by-round transformation, wherein the method is specifically implemented as follows:
(1) Construction of tHMG1 recombinant expression vector
The saccharomyces cerevisiae genome is used as a template, primers tHMG1-F/tHMG1-R are designed to amplify a target gene tHMG1 (shown as SEQ ID NO. 2), the target gene tHMG1 is assembled with a vector Int12-pGAP-tAOX1 (Int 12: left gene PAS_chr3_1202 and right gene PAS_chr3_0618) which is subjected to enzyme digestion by an aatII through a seamless cloning method, and an escherichia coli DH5 alpha strain is transformed to obtain a recombinant vector Int12-pGAP-tHMG1-tAOX1.
The primer sequences used were as follows:
tHMG1-F:aatcaattgaacaactatcaaaacacaGATGGCTGCAGACCAATTGGTG;
tHMG1-R:aggcaaatggcattctgacatCCTCTTGAGTTAGGATTTAATGCAGGTG。
(2) Construction of guide RNA recombinant expression vector HZP-sgRNA-Int12
Starting from helper plasmid HZP-sgRNA (plasmid map is shown in FIG. 5), primers Int12-sgRNA-F and Int12-sgRNA-R are designed, the Int12-sgRNA is introduced by using enzyme cutting site BsaI in the vector HZP-sgRNA, and the recombinant vector HZP-sgRNA-Int12 is obtained through T4 enzyme connection.
The primer sequences used were as follows:
Int12-sgRNA-F:acgcggggtttgaataacagacac;
Int12-sgRNA-R:AAACgtgtctgttattcaaacccc。
(3) Construction of Pichia santalene recombinant strain Pa-1-1
The recombinant vector Int12-pGAP-tHMG1-tAOX1 is used as a template to design primers Int12-donor-F and Int12-donor-R, PCR is carried out to obtain a corresponding linearized fragment Int12-donor, and the linearized fragment Int12-donor and a corresponding recombinant guide plasmid HZP-sgRNA-Int12 are simultaneously transformed into Pichia pastoris cells Pa-1 to obtain recombinant strains Pa-1-1. The resistant plasmid was discarded at the same time as passaging several times.
The primer sequences used were as follows:
Int12-donor-F:CTGGGcagtagtgaattggttg;Int12-donor-R:acattgttcgtgaggctaatcc。
(4) Construction of recombinant expression vector for coding gene of isopentenyl pyrophosphate isomerase IDI1
The primers IDI1-F/IDI1-R are designed, a target gene IDI1 (shown as SEQ ID NO. 3) is amplified from the genome of Pichia pastoris GS115, and assembled with a BamHI digested vector Int1-pTEF-tAOX1 (Int 1: left gene PAS_FragB_0066 and right gene PAS_FragB_0067) by a seamless cloning method, and an escherichia coli DH5 alpha strain is transformed to obtain a recombinant vector Int1-pTEF-IDI1-tAOX1.
The primer sequences used were as follows:
IDI1-F:catacattttagttattcgccaacGatgactgccgacaacaatagtatg;
IDI1-R:AAATGGCATTCTGACATCCTCTTGAGttatagcattctatgaatttgcc。
(5) Construction of guide RNA recombinant expression vector HHP-sgRNA-Int1
Starting from helper plasmid HHP-sgRNA (plasmid map is shown in FIG. 6), primers Int1-sgRNA-F and Int1-sgRNA-R are designed, the Int1-sgRNA is introduced by using enzyme cleavage site BsaI in the vector HHP-sgRNA, and the recombinant vector HHP-sgRNA-Int1 is obtained through T4 enzyme ligation.
The primer sequences used were as follows:
Int1-sgRNA-F:acgctatctgaagtatttactggg;
Int1-sgRNA-R:AAACcccagtaaatacttcagata。
(6) Construction of Pichia santalene recombinant strain Pa-1-2
The recombinant vector Int1-pTEF-IDI1-tAOX1 is used as a template to design primers Int1-donor-F and Int1-donor-R, PCR is carried out to obtain a corresponding linearized fragment Int1-donor, and the linearized fragment Int1-donor and a corresponding recombinant guide plasmid HHP-sgRNA-Int1 are simultaneously transformed into Pichia pastoris cells Pa-1-1 to obtain recombinant strains Pa-1-2. The resistant plasmid was discarded at the same time as passaging several times.
The primer sequences used were as follows:
Int1-donor-F:CTGGGcagtagtgaattggttg;Int1-donor-R:acattgttcgtgaggctaatcc。
(7) Construction of recombinant expression vector of encoding gene of farnesyl pyrophosphoric acid synthetase ERG20
The primer ERG20-F/ERG20-R is designed to amplify a target gene ERG20 (shown as SEQ ID NO. 4), the target gene ERG20 is assembled with a vector Int20-pGAP-tAOX1 (Int 20: left gene PAS_chr4_0465 and right gene PAS_chr4_ 0467) which is subjected to enzyme digestion by an Aat II through a seamless cloning method, and an escherichia coli DH5 alpha strain is transformed to obtain a recombinant vector Int20-pGAP-ERG20-tAOX1.
The primer sequences used were as follows:
ERG20-F:caattgaacaactatcaaaacacaGatggcttcagaaaaagaaattagg;
ERG20-R:GCAAATGGCATTCTGACATCCTCTTGAGctatttgcttctcttgtaaac。
(8) Construction of guide RNA recombinant expression vector HGP-sgRNA-Int20
Starting from helper plasmid HGP-sgRNA (plasmid map is shown in figure 7), primers Int20-sgRNA-F and Int20-sgRNA-R are designed, the Int20-sgRNA is introduced by using enzyme cutting site BsaI in the vector HGP-sgRNA, and the recombinant vector HGP-sgRNA-Int20 is obtained through T4 enzyme connection.
The primer sequences used were as follows:
Int20-sgRNA-F:acgcagaagaaaatgcgaaacagg;
Int20-sgRNA-R:AAACcctgtttcgcattttcttct。
(9) Construction of Pichia santalene recombinant strain Pa-2
The recombinant vector Int20-pGAP-ERG20-tAOX1 is used as a template to design primers Int20-donor-F and Int20-donor-R, PCR is carried out to obtain a corresponding linearized fragment Int20-donor, and the linearized fragment Int20-donor and a corresponding recombinant guide plasmid HGP-sgRNA-Int20 are simultaneously transformed into pichia pastoris cells Pa-1-2 to obtain recombinant strains Pa-2. The resistant plasmid was discarded at the same time as passaging several times.
The primer sequences used were as follows:
Int20-donor-F:tccgatcattgcatagatacc;Int20-donor-R:ttggtcagaattacttcacac。
example 3: construction of Pichia santalene recombinant strain Pa-3
Constructing an expression cassette of a coding gene of high-expression acetyl-CoA synthase ACS and a corresponding guide plasmid, electrically converting the expression cassette into the recombinant strain Pa-2 to finally obtain a pichia pastoris recombinant strain Pa-3, and specifically implementing the following steps:
(1) Construction of recombinant expression vector for coding gene of ACS (acetyl-CoA synthase)
The acetyl-CoA synthase ACS plasmid stored in a laboratory is used as a template, a primer ACS-F/ACS-R is designed to amplify a target gene ACS (shown as SEQ ID NO. 5), the target gene ACS is assembled with a BamHI digested vector Int16-pTEF-tAOX1 (Int 16: left gene PAS_chr3_1065 and right gene PAS_chr3_1067) by a seamless cloning method, and an escherichia coli DH5 alpha strain is transformed to obtain a recombinant vector Int16-pTEF-ACS-tAOX1.
The primer sequences used were as follows:
ACS-F:acatacattttagttattcgccaacGatgtcacaaacacacaaacatgc;
ACS-R:AATGGCATTCTGACATCCTCTTGAGtcatgatggcatagcaatagcttg。
(2) Construction of vector HZP-sgRNA-Int16 for recombinant expression of guide RNA
Starting from helper plasmid HZP-sgRNA, designing primers Int16-sgRNA-F and Int16-sgRNA-R, introducing Int16-sgRNA by using enzyme cutting site BsaI in the vector HZP-sgRNA, and connecting by T4 enzyme to obtain recombinant vector HZP-sgRNA-Int16.
The primer sequences used were as follows:
Int16-sgRNA-F:acgcgatatgaagagcaaacacag;
Int16-sgRNA-R:AAACctgtgtttgctcttcatatc。
(3) Construction of Pichia santalene recombinant strain Pa-3
The recombinant vector Int16-pTEF-ACS-tAOX1 is used as a template to design primers Int16-donor-F and Int16-donor-R, PCR is carried out to obtain a corresponding linearized fragment Int16-donor, and the linearized fragment Int16-donor and a corresponding recombinant guide plasmid HZP-sgRNA-Int16 are simultaneously transformed into Pichia pastoris cells Pa-2 to obtain recombinant strains Pa-3. The resistant plasmid was discarded at the same time as passaging several times.
The primer sequences used were as follows:
Int16-donor-F:acaccaccacaaatacctaccaatg;
Int16-donor-R:acctgggagaatgttttcaatctgg。
example 4: construction of multicopy santalene Pichia pastoris recombinant strain Pa-4
Constructing an expression cassette of a coding gene of the santalene synthase SAS and a corresponding guide plasmid, sequentially transferring the expression cassette and the corresponding guide plasmid into the recombinant strain Pa-3, and finally obtaining a recombinant strain Pa-4 through transformation, wherein the method is implemented as follows:
(1) Construction of SAS recombinant expression vector
The coding gene of the santalene synthase SAS in example 1 was assembled with BamHI digested vector Int33-pTEF-tAOX1 (Int 33: left gene PAS_chr1-1_0053, right gene PAS_chr1-1_0054) and Int6-pTEF-tAOX1 (Int 6: left gene PAS_chr2-1_0010, right gene PAS_chr2-1_0011) by a seamless cloning method, and recombinant vectors Int33-pTEF-SAS-tAOX1 and Int6-pTEF-SAS-tAOX1 were obtained after transformation of E.coli DH 5. Alpha. Respectively. The primer sequences used were the same as in example 1.
(2) Construction of guide RNA recombinant expression vectors HGP-sgRNA-Int33 and HHP-sgRNA-Int6
Starting from helper plasmid HGP-sgRNA, designing primers Int33-sgRNA-F and Int33-sgRNA-R, introducing Int33-sgRNA by using enzyme cutting sites BsaI in the vector HGP-sgRNA, and connecting by T4 enzyme to obtain a recombinant vector HGP-sgRNA-Int33; starting from helper plasmid HHP-sgRNA, primers Int6-sgRNA-F and Int6-sgRNA-R are designed, the Int6-sgRNA is introduced by using enzyme cutting sites BsaI in the vector HHP-sgRNA, and the recombinant vector HHP-sgRNA-Int6 is obtained through T4 enzyme connection.
The primer sequences used were as follows:
Int33-sgRNA-F:acgcccgtcactatgaggacaaag;
Int33-sgRNA-R:AAACctttgtcctcatagtgacgg;
Int6-sgRNA-F:gacgctatctgtgtaaagcgacgag;
Int6-sgRNA-R:AAACctcgtcgctttacacagata。
(3) Construction of Pichia santalene recombinant strain Pa-4
The recombinant vector Int33-pTEF-SAS-tAOX1 is used as a template to design primers Int33-donor-F and Int33-donor-R, PCR is carried out to obtain a corresponding linearized fragment Int33-donor, and the linearized fragment Int33-donor and a corresponding recombinant guide plasmid HGP-sgRNA-Int33 are simultaneously transformed into Pichia pastoris cells Pa-3 to obtain recombinant strains Pa-3-1. The recombinant vector Int6-pTEF-SAS-tAOX1 is used as a template to design primers Int6-donor-F and Int6-donor-R, PCR is carried out to obtain a corresponding linearized fragment Int6-donor, and the linearized fragment Int6-donor and a corresponding recombinant guide plasmid HHP-sgRNA-Int6 are simultaneously transformed into Pichia pastoris cells Pa-3-1 to obtain recombinant strains Pa-4. The two rounds of serially transformed resistant plasmid were discarded at the same time as passaging several times. The primer sequences used were as follows:
Int33-donor-F:aaagagagagtctaaaagtggtg;Int33-donor-R:attataattagcacggtgttgc;
Int6-donor-F:agtaagggcagtgtaccatag;Int6-donor-R:acattaagaaccaagatcatgca。
example 5: efficient production of santalene by pichia pastoris engineering strain
The recombinant strains in examples 1-4 were activated by solid YPD plates, single colonies were picked up and cultured in 5mL test tubes, and then transferred to 50mL shake flasks at 1% inoculum size for 5 days, and the post-treated samples were subjected to product analysis. And (3) carrying out fed-batch culture in a fermentation tank by Pa-4 to obtain a high-concentration fermentation product. The specific implementation is as follows:
(1) Cultivation of recombinant strains
GS115-Cas9, pa-1, pa-2, pa-3 and Pa-4 single colonies were picked from the plates, inoculated into 5mL YPD (glucose 20g/L, peptone 20g/L, yeast extract 10 g/L) tubes, cultured at 30℃for 12 hours at 250rpm, then inoculated into 50mL YPD shake flask medium at 1% inoculum size, three strains each in parallel, the medium upper layer was covered with 10% n-dodecane, cultured at 30℃for 5 days at 250rpm, and 2% glucose was supplemented every 24 hours.
(2) Method for detecting santalene
Sample treatment: the upper layer fermentation broth was centrifuged at 12000rpm for 3min, the upper layer organic phase was filtered through a 0.22 μm nylon filter, and the sample was diluted 10-fold with ethyl acetate and subjected to GC-MS detection.
GC-MS detection conditions: chromatographic conditions: DB-5MS capillary chromatographic column; mass spectrometry conditions: EI+ ionization source; electron energy 70eV; the temperature of the ion source is 250 ℃; the temperature of the sample inlet is 250 ℃; delaying the solvent for 10min; full mass spectrum scanning, 40-500m/z. Detection procedure: the initial temperature is 40 ℃, and the temperature is kept for 3min; heating to 130 ℃ at a speed of 10 ℃/min, heating to 180 ℃ at a speed of 3 ℃/min, heating to 300 ℃ at a speed of 50 ℃/min, and maintaining for 10min. And (3) split sampling, wherein the split ratio is 20:1, and the sampling amount is 1 mu L.
(3) Recombinant strain Pa-4 fermentation tank culture
Starting from recombinant strain Pa-4 of Pichia pastoris, inoculating single colony of Pa-4 activated on YPD plate into 5mL YPD test tube, culturing for 12h, inoculating 1% of the strain into 50mL YPD liquid culture medium, culturing for 12h as seed liquid under 30 ℃ and shaking table rotation speed of 250rpm, inoculating 10% of the strain into 1L fermentation tank (liquid loading volume of 600 mL), culturing at 30 ℃ and correcting dissolved oxygen DO to 100%, tank pressure of 0.8 atm, fermenting for 24h, and adding 10% (v/v) sterile filtered n-dodecane. When the mass fraction of glucose in the fermentation tank is reduced to 1%, adding 40% (v/v) of glucose solution, controlling the stirring rotation speed to 200-800rpm, keeping dissolved oxygen above 20%, adding 25% ammonia water and 18% acetic acid in the final fermentation period, adjusting pH value to 5.5-6.0, and ending fermentation after 96 hours.
(4) Recombinant strain santalene yield comparison
TABLE 1
Pichia pastoris engineering strains are cultivated according to the cultivation method described in (1), the santalene yield is determined by the detection method described in (2), the detection mass spectrum is shown in FIG. 8 and FIG. 10, and the yield in shake flasks is shown in Table 1 and FIG. 9. The pichia pastoris engineering strain Pa-4 is subjected to fed-batch fermentation according to the method shown in the step (3), the maximum yield of the santalene in a 1L fermentation tank after 96 hours is about 15g/L, the highest yield reported at present is established, a foundation is laid for the industrial production and application of the alpha-santalene and high-added value derivatives thereof, and reference can be provided for the efficient green biological production of other terpene natural products.
Sequence listing
<110> Hangzhou International science center of Zhejiang university
<120> Yeast engineering bacterium for producing alpha-santalene by fermentation and application thereof
<160> 46
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1656
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
atgtctactc aacaagtttc ttctgaaaac atcgttagaa acgctgctaa cttccaccca 60
aacatctggg gtaaccactt cttgacttgt ccatctcaaa ctatcgactc ttggactcaa 120
caacaccaca aggaattgaa ggaagaagtt agaaagatga tggtttctga cgctaacaag 180
ccagctcaaa gattgagatt gatcgacact gttcaaagat tgggtgttgc ttaccacttc 240
gaaaaggaaa tcgacgacgc tttggaaaag atcggtcacg acccattcga cgacaaggac 300
gacttgtaca tagttagctt gtgtttcaga ctcttgagac aacacggtat caagatctct 360
tgtgacgttt tcgaaaagtt caaggacgac gacggtaagt tcaaggcttc tttgatgaac 420
gacgttcaag gtatgttgtc tttgtacgaa gctgctcact tggctatcca cggtgaagac 480
atcttggacg aagctatcgt tttcactact actcacttga agtctactgt ttctaactct 540
ccagttaact ctactttcgc tgaacaaatc agacactctt tgagagttcc attgagaaag 600
gctgttccaa gattggaatc tagatacttc ttggacatct actctagaga cgacctccat 660
gacaagacat tgttgaactt cgcgaagttg gacttcaaca tcttgcaagc tatgcaccaa 720
aaggaagctt ctgaaatgac tagatggtgg agagacttcg acttcttgaa gaagttgcca 780
tacatcagag acagagttgt tgaattgtac ttctggatct tggttggtgt ttcttaccaa 840
ccaaagttct ctactggtag aatcttcttg tctaagatca tctgtttgga aactttggtt 900
gacgacactt tcgacgctta cggtactttc gacgaattgg ctatcttcac tgaagctgtt 960
actagatggg acttgggtca cagagacgct ttgccagaat acatgaagtt tatattcaag 1020
actctcatcg acgtttactc tgaagctgaa caagaattgg ctaaggaagg tagatcttac 1080
tctatccact acgctatcag atctttccaa gaattggtta tgaagtactt ctgtgaagct 1140
aagtggttga acaagggtta cgttccatct ttggacgact acaaatctgt gagcttgaga 1200
tctatcggtt tcttgccaat cgctgttgct tctttcgttt tcatgggtga catcgctact 1260
aaggaagttt tcgaatggga aatgaacaac ccaaagatca tcatcgctgc tgaaactatc 1320
ttcagattct tggacgacat cgctggtcac agattcgaac aaaagagaga acactctcca 1380
tctgctatcg aatgttacaa gaaccaacac ggtgtttctg aagaagaagc tgttaaggct 1440
ttgtctttgg aagttgctaa ctcttggaag gacatcaacg aagaattgtt gttgaaccca 1500
atggctatcc cattgccatt gttgcaagtt atcttggact tgtctagatc tgctgacttc 1560
atgtacggta acgctcaaga cagattcact cactctacta tgatgaagga ccaggttgat 1620
ttggtcctga aggacccagt taagttggac gactaa 1656
<210> 2
<211> 1584
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
atggctgcag accaattggt gaaaactgaa gtcaccaaga agtcttttac tgctcctgta 60
caaaaggctt ctacaccagt tttaaccaat aaaacagtca tttctggatc gaaagtcaaa 120
agtttatcat ctgcgcaatc gagctcatca ggaccttcat catctagtga ggaagatgat 180
tcccgcgata ttgaaagctt ggataagaaa atacgtcctt tagaagaatt agaagcatta 240
ttaagtagtg gaaatacaaa acaattgaag aacaaagagg tcgctgcctt ggttattcac 300
ggtaagttac ctttgtacgc tttggagaaa aaattaggtg atactacgag agcggttgcg 360
gtacgtagga aggctctttc aattttggca gaagctcctg tattagcatc tgatcgttta 420
ccatataaaa attatgacta cgaccgcgta tttggcgctt gttgtgaaaa tgttataggt 480
tacatgcctt tgcccgttgg tgttataggc cccttggtta tcgatggtac atcttatcat 540
ataccaatgg caactacaga gggttgtttg gtagcttctg ccatgcgtgg ctgtaaggca 600
atcaatgctg gcggtggtgc aacaactgtt ttaactaagg atggtatgac aagaggccca 660
gtagtccgtt tcccaacttt gaaaagatct ggtgcctgta agatatggtt agactcagaa 720
gagggacaaa acgcaattaa aaaagctttt aactctacat caagatttgc acgtctgcaa 780
catattcaaa cttgtctagc aggagattta ctcttcatga gatttagaac aactactggt 840
gacgcaatgg gtatgaatat gatttctaaa ggtgtcgaat actcattaaa gcaaatggta 900
gaagagtatg gctgggaaga tatggaggtt gtctccgttt ctggtaacta ctgtaccgac 960
aaaaaaccag ctgccatcaa ctggatcgaa ggtcgtggta agagtgtcgt cgcagaagct 1020
actattcctg gtgatgttgt cagaaaagtg ttaaaaagtg atgtttccgc attggttgag 1080
ttgaacattg ctaagaattt ggttggatct gcaatggctg ggtctgttgg tggatttaac 1140
gcacatgcag ctaatttagt gacagctgtt ttcttggcat taggacaaga tcctgcacaa 1200
aatgttgaaa gttccaactg tataacattg atgaaagaag tggacggtga tttgagaatt 1260
tccgtatcca tgccatccat cgaagtaggt accatcggtg gtggtactgt tctagaacca 1320
caaggtgcca tgttggactt attaggtgta agaggcccgc atgctaccgc tcctggtacc 1380
aacgcacgtc aattagcaag aatagttgcc tgtgccgtct tggcaggtga attatcctta 1440
tgtgctgccc tagcagccgg ccatttggtt caaagtcata tgacccacaa caggaaacct 1500
gctgaaccaa caaaacctaa caatttggac gccactgata taaatcgttt gaaagatggg 1560
tccgtcacct gcattaaatc ctaa 1584
<210> 3
<211> 867
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
atgactgccg acaacaatag tatgccccat ggtgcagtat ctagttacgc caaattagtg 60
caaaaccaaa cacctgaaga cattttggaa gagtttcctg aaattattcc attacaacaa 120
agacctaata cccgatctag tgagacgtca aatgacgaaa gcggagaaac atgtttttct 180
ggtcatgatg aggagcaaat taagttaatg aatgaaaatt gtattgtttt ggattgggac 240
gataatgcta ttggtgccgg taccaagaaa gtttgtcatt taatggaaaa tattgaaaag 300
ggtttactac atcgtgcatt ctccgtcttt attttcaatg aacaaggtga attactttta 360
caacaaagag ccactgaaaa aataactttc cctgatcttt ggactaacac atgctgctct 420
catccactat gtattgatga cgaattaggt ttgaagggta agctagacga taagattaag 480
ggcgctatta ctgcggcggt gagaaaacta gatcatgaat taggtattcc agaagatgaa 540
actaagacaa ggggtaagtt tcacttttta aacagaatcc attacatggc accaagcaat 600
gaaccatggg gtgaacatga aattgattac atcctatttt ataagatcaa cgctaaagaa 660
aacttgactg tcaacccaaa cgtcaatgaa gttagagact tcaaatgggt ttcaccaaat 720
gatttgaaaa ctatgtttgc tgacccaagt tacaagttta cgccttggtt taagattatt 780
tgcgagaatt acttattcaa ctggtgggag caattagatg acctttctga agtggaaaat 840
gacaggcaaa ttcatagaat gctataa 867
<210> 4
<211> 1059
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
atggcttcag aaaaagaaat taggagagag agattcttga acgttttccc taaattagta 60
gaggaattga acgcatcgct tttggcttac ggtatgccta aggaagcatg tgactggtat 120
gcccactcat tgaactacaa cactccaggc ggtaagctaa atagaggttt gtccgttgtg 180
gacacgtatg ctattctctc caacaagacc gttgaacaat tggggcaaga agaatacgaa 240
aaggttgcca ttctaggttg gtgcattgag ttgttgcagg cttacttctt ggtcgccgat 300
gatatgatgg acaagtccat taccagaaga ggccaaccat gttggtacaa ggttcctgaa 360
gttggggaaa ttgccatcaa tgacgcattc atgttagagg ctgctatcta caagcttttg 420
aaatctcact tcagaaacga aaaatactac atagatatca ccgaattgtt ccatgaggtc 480
accttccaaa ccgaattggg ccaattgatg gacttaatca ctgcacctga agacaaagtc 540
gacttgagta agttctccct aaagaagcac tccttcatag ttactttcaa gactgcttac 600
tattctttct acttgcctgt cgcattggcc atgtacgttg ccggtatcac ggatgaaaag 660
gatttgaaac aagccagaga tgtcttgatt ccattgggtg aatacttcca aattcaagat 720
gactacttag actgcttcgg taccccagaa cagatcggta agatcggtac agatatccaa 780
gataacaaat gttcttgggt aatcaacaag gcattggaac ttgcttccgc agaacaaaga 840
aagactttag acgaaaatta cggtaagaag gactcagtcg cagaagccaa atgcaaaaag 900
attttcaatg acttgaaaat tgaacagcta taccacgaat atgaagagtc tattgccaag 960
gatttgaagg ccaaaatttc tcaggtcgat gagtctcgtg gcttcaaagc tgatgtctta 1020
actgcgttct tgaacaaagt ttacaagaga agcaaatag 1059
<210> 5
<211> 1959
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
atgtcacaaa cacacaaaca tgctattcct gcgaatatcg ctgacaggtg cttaatcaac 60
cctgaacaat acgaaacgaa gtacaagcag tctatcaacg atcctgatac tttctggggc 120
gagcaaggta agatactcga ttggattact ccatatcaaa aggtcaaaaa cacatccttt 180
gctcctggaa atgtgtcaat caagtggtac gaggacggca ctctaaacct agctgctaat 240
tgcttggatc gacacctcca ggaaaatggt gacagaacgg caatcatttg ggaaggtgat 300
gatacttctc aatctaagca catctcctac agagagttac acagagatgt ttgcagattc 360
gcgaatactt tactggacct gggtatcaaa aagggcgatg ttgtggcaat ctacatgcct 420
atggtcccag aggcagctgt ggcaatgttg gcctgtgcca gaataggagc agtccatagc 480
gttatctttg gcggattctc ccctgaagcc gttgctggga gaatcattga ctcatcaagt 540
agattagtta tcactgccga cgaaggtgtt agagcaggta gatccatccc attgaagaaa 600
aacgttgatg acgcgttgaa aaacccaaac gttacgagtg tggagcatgt aattgtacta 660
aagcgtaccg gctctgatat agactggcag gaaggtaggg atttgtggtg gagagatctt 720
attgagaaag caagtccaga acaccaacca gaagcaatga atgcggaaga tccattgttc 780
atcttgtata catctgggtc aactggcaaa ccaaaaggtg ttttgcatac aacaggtggt 840
tatctcgtat acgccgcaac aacctttaag tacgtttttg attaccatcc aggtgatatc 900
tactggtgta ccgctgatgt cggttgggtt actggtcata gttacctgct ttacggtcca 960
ctggcatgcg gcgcaaccac tttgatgttt gaaggagtac caaactggcc aaccccagcc 1020
aggatgtgtc aagtggtcga taaacaccaa gtgaacatat tgtacacagc cccaaccgcc 1080
attagagcgc taatggccga aggagataag gcgattgagg gaacagatag aagtagccta 1140
cgtatcttag gatccgttgg cgagccaatc aatccagaag cttgggaatg gtattggaaa 1200
aagattggta aggaaaagtg tccagtagtg gatacatggt ggcaaactga aacaggtgga 1260
ttcatgatta cacctcttcc aggtgcaata gaattgaagg ctgggtctgc tactaggcct 1320
ttcttcggcg tccaacctgc tttagtagac aacgaagggc atccacaaga gggggcaaca 1380
gaaggcaatc tagtgataac tgattcctgg cctggtcagg ctagaacatt gtttggtgat 1440
cacgaaagat tcgaacaaac ctatttctca actttcaaaa acatgtattt cagcggtgac 1500
ggtgcgagaa gagacgaaga tgggtactac tggattaccg gcagagtaga tgacgtcctt 1560
aacgtatctg gacatcgtct gggtacagct gagattgagt cagctttagt tgctcatcct 1620
aagattgctg aagctgcagt cgttggcatc ccacacgcta tcaagggtca agccatatac 1680
gcatatgtta cactcaacca tggtgaggaa ccatctccag agctatacgc agaggtcaga 1740
aattgggttc gaaaggaaat agggccttta gccacaccag atgttttgca ttggacagat 1800
tcattgccta agacaagatc tggaaagatt atgagacgta tacttagaaa gatcgccgcc 1860
ggagatacgt ctaacttagg tgatacttct actcttgccg atccaggcgt ggtcgaaaaa 1920
cctttagagg aaaaacaagc tattgctatg ccatcatga 1959
<210> 6
<211> 424
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
ataactgtcg cctcttttat ctgccgcact gcatgaggtg tccccttagt gggaaagagt 60
actgagccaa ccctggagga cagcaaggga aaaataccta caacttgctt cataatggtc 120
gtaaaaacaa tccttgtcgg atataagtgt tgtagactgt cccttatcct ctgcgatgtt 180
cttcctctca aagtttgcga tttctctcta tcagaattgc catcaagaga ctcaggacta 240
atttcgcagt cccacacgca ctcgtacatg attggctgaa atttccctaa agaatttctt 300
tttcacgaaa attttttttt tacacaagat tttcagcaga tataaaatgg agagcaggac 360
ctccgctgtg actcttcttt tttttctttt attctcacta catacatttt agttattcgc 420
caac 424
<210> 7
<211> 1000
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
ctgctactct ggtcccaagt gaaccacctt ttggacccta ttgaccggac cttaacttgc 60
caaacctaaa cgcttaatgc ctcagacgtt ttaatgcctc tcaacacctc caaggttgct 120
ttcttgagca tgcctactag gaactttaac gaactgtggg gttgcagaca gtttcaggcg 180
tgtcccgacc aatatggcct actagactct ctgaaaaatc acagttttcc agtagttccg 240
atcaaattac catcgaaatg gtcccataaa cggacatttg acatccgttc ctgaattata 300
gtcttccacc gtggatcatg gtgttccttt ttttcccaaa gaatatcagc atcccttaac 360
tacgttaggt cagtgatgac aatggaccaa attgttgcaa ggtttttctt tttctttcat 420
cggcacattt cagcctcaca tgcgactatt atcgatcaat gaaatccatc aagattgaaa 480
tcttaaaatt gcccctttca cttgacagga tccttttttg tagaaatgtc ttggtgtcct 540
cgtccaatca ggtagccatc tctgaaatat ctggctccgt tgcaactccg aacgacctgc 600
tggcaacgta aaattctccg gggtaaaact taaatgtgga gtaatggaac cagaaacgtc 660
tcttcccttc tctctccttc caccgcccgt taccgtccct aggaaatttt actctgctgg 720
agagcttctt ctacggcccc cttgcagcaa tgctcttccc agcattacgt tgcgggtaaa 780
acggaggtcg tgtacccgac ctagcagccc agggatggaa aagtcccggc cgtcgctggc 840
aataatagcg ggcggacgca tgtcatgaga ttattggaaa ccaccagaat cgaatataaa 900
aggcgaacac ctttcccaat tttggtttct cctgacccaa agactttaaa tttaatttat 960
ttgtccctat ttcaatcaat tgaacaacta tcaaaacaca 1000
<210> 8
<211> 247
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
tcaagaggat gtcagaatgc catttgcctg agagatgcag gcttcatttt tgatactttt 60
ttatttgtaa cctatatagt ataggatttt ttttgtcatt ttgtttcttc tcgtacgagc 120
ttgctcctga tcagcctatc tcgcagctga tgaatatctt gtggtagggg tttgggaaaa 180
tcattcgagt ttgatgtttt tcttggtatt tcccactcct cttcagagta cagaagatta 240
agtgaga 247
<210> 9
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
atacatttta gttattcgcc aacgatgtct actcaacaag tttcttctg 49
<210> 10
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 10
caaatggcat tctgacatcc tcttgagtta gtcgtccaac ttaactggg 49
<210> 11
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 11
acgctcacgg attcaggaaa tacg 24
<210> 12
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 12
aaaccgtatt tcctgaatcc gtga 24
<210> 13
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 13
agaaggcaaa gaatcttctg ac 22
<210> 14
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 14
taggctaaac caagtgattt ttc 23
<210> 15
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
aatcaattga acaactatca aaacacagat ggctgcagac caattggtg 49
<210> 16
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
aggcaaatgg cattctgaca tcctcttgag ttaggattta atgcaggtg 49
<210> 17
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 17
acgcggggtt tgaataacag acac 24
<210> 18
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 18
aaacgtgtct gttattcaaa cccc 24
<210> 19
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 19
ctgggcagta gtgaattggt tg 22
<210> 20
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 20
acattgttcg tgaggctaat cc 22
<210> 21
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 21
catacatttt agttattcgc caacgatgac tgccgacaac aatagtatg 49
<210> 22
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 22
aaatggcatt ctgacatcct cttgagttat agcattctat gaatttgcc 49
<210> 23
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 23
acgctatctg aagtatttac tggg 24
<210> 24
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 24
aaaccccagt aaatacttca gata 24
<210> 25
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 25
ctgggcagta gtgaattggt tg 22
<210> 26
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 26
acattgttcg tgaggctaat cc 22
<210> 27
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 27
caattgaaca actatcaaaa cacagatggc ttcagaaaaa gaaattagg 49
<210> 28
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 28
gcaaatggca ttctgacatc ctcttgagct atttgcttct cttgtaaac 49
<210> 29
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 29
acgcagaaga aaatgcgaaa cagg 24
<210> 30
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 30
aaaccctgtt tcgcattttc ttct 24
<210> 31
<211> 21
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 31
tccgatcatt gcatagatac c 21
<210> 32
<211> 21
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 32
ttggtcagaa ttacttcaca c 21
<210> 33
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 33
acatacattt tagttattcg ccaacgatgt cacaaacaca caaacatgc 49
<210> 34
<211> 49
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 34
aatggcattc tgacatcctc ttgagtcatg atggcatagc aatagcttg 49
<210> 35
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 35
acgcgatatg aagagcaaac acag 24
<210> 36
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 36
aaacctgtgt ttgctcttca tatc 24
<210> 37
<211> 25
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 37
acaccaccac aaatacctac caatg 25
<210> 38
<211> 25
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 38
acctgggaga atgttttcaa tctgg 25
<210> 39
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 39
acgcccgtca ctatgaggac aaag 24
<210> 40
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 40
aaacctttgt cctcatagtg acgg 24
<210> 41
<211> 25
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 41
gacgctatct gtgtaaagcg acgag 25
<210> 42
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 42
aaacctcgtc gctttacaca gata 24
<210> 43
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 43
aaagagagag tctaaaagtg gtg 23
<210> 44
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 44
attataatta gcacggtgtt gc 22
<210> 45
<211> 21
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 45
agtaagggca gtgtaccata g 21
<210> 46
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 46
acattaagaa ccaagatcat gca 23
Claims (5)
1. The yeast engineering bacteria for producing alpha-santalene by fermentation is characterized in that pichia pastoris is used as an original strain, the yeast engineering bacteria are obtained by constructing an introduced gene, and the introduced gene comprises any one of the following groups:
(1) A coding gene for santalene synthase SAS, a coding gene for 3-hydroxy-3-methylglutaryl-coa reductase 1 tgmg 1, a coding gene for isopentenyl pyrophosphate isomerase IDI1, a coding gene for farnesyl pyrophosphate synthase ERG20, and a coding gene for acetyl-coa synthase ACS;
(2) A coding gene of santalene synthase SAS, a coding gene of 3-hydroxy-3-methylglutaryl coenzyme A reductase 1tHMG1, a coding gene of isopentenyl pyrophosphate isomerase IDI1 and a coding gene of farnesyl pyrophosphate synthase ERG 20;
the coding gene of the santalene synthase SAS is shown as SEQ ID NO.1, the coding gene of the 3-hydroxy-3-methylglutaryl coenzyme A reductase 1tHMG1 is shown as SEQ ID NO.2, the coding gene of the isopentenyl pyrophosphate isomerase IDI1 is shown as SEQ ID NO.3, the coding gene of the farnesyl pyrophosphate synthase ERG20 is shown as SEQ ID NO.4, and the coding gene of the acetyl coenzyme A synthase ACS is shown as SEQ ID NO. 5;
the pichia pastoris is pichia pastoris GS115-Cas9, and is obtained by introducing a Cas9 protein coding gene into a genome of a pichia pastoris GS115 strain;
the coding genes of the santalene synthase SAS in the introduced genes are 3 copies, and other coding genes are single copies;
the promoter used in the yeast engineering bacteria is pTEF or pGAP obtained by introducing gene construction; the terminator is tAOX1.
2. The method for constructing a yeast engineering bacterium for producing α -santalene by fermentation according to claim 1, wherein the introduced genes include a coding gene for santalene synthase SAS, a coding gene for 3-hydroxy-3-methylglutaryl-coa reductase 1 tgmg 1, a coding gene for isopentenyl pyrophosphate isomerase IDI1, a coding gene for farnesyl pyrophosphate synthase ERG20, and a coding gene for acetyl-coa synthase ACS, the method comprising the steps of:
(1) Integrating a coding gene sequence of a santalene synthase SAS into a genome of Pichia pastoris GS115-Cas9 to obtain a strain Pa-1;
(2) Integrating the coding gene sequence of 3-hydroxy-3-methylglutaryl coenzyme A reductase 1tHMG1, the coding gene sequence of isopentenyl pyrophosphate isomerase IDI1 and the coding gene sequence of farnesyl pyrophosphate synthetase ERG20 into a strain Pa-1 to obtain a strain Pa-2;
(3) Integrating the coding gene sequence of acetyl-CoA synthase ACS into the strain Pa-2 to obtain a strain Pa-3;
(4) 2 coding gene sequences of single copy santalene synthase SAS are integrated into a strain Pa-3 to obtain a strain Pa-4, namely the yeast engineering bacteria for producing alpha-santalene by fermentation.
3. The use of a yeast engineering bacterium for producing α -santalene by fermentation according to claim 1 in the preparation of α -santalene.
4. A method for preparing alpha-santalene, which is characterized in that the yeast engineering bacteria for producing the alpha-santalene by fermentation in claim 1 are cultivated by fermentation, and the alpha-santalene is extracted.
5. The method for preparing alpha-santalene according to claim 4, wherein the fermentation tank is used for fermenting yeast engineering bacteria for producing alpha-santalene, and the culturing method comprises the following steps: transferring the seed solution of the yeast engineering strain into a 1L fermentation tank with 10% of inoculation amount, culturing at 30 ℃, correcting dissolved oxygen DO to be 100%, fermenting at 24h and adding 10% of sterile filtered n-dodecane; and (3) when the mass fraction of glucose in the fermentation tank is reduced to 1%, feeding a glucose solution with the mass fraction of 40%, controlling the stirring rotation speed to be 200-800rpm, keeping dissolved oxygen to be more than 20%, feeding ammonia water with the volume fraction of 25% and acetic acid with the volume fraction of 18% in the later fermentation period, and finishing fermentation after regulating the pH value in the fermentation tank to be 5.5-6.0 and 96 and h.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210093958.4A CN114507613B (en) | 2022-01-26 | 2022-01-26 | Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof |
PCT/CN2023/072128 WO2023143136A1 (en) | 2022-01-26 | 2023-01-13 | YEAST ENGINEERING BACTERIUM FOR FERMENTATIVE PRODUCTION OF α-SANTALENE AND USE THEREOF |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210093958.4A CN114507613B (en) | 2022-01-26 | 2022-01-26 | Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114507613A CN114507613A (en) | 2022-05-17 |
CN114507613B true CN114507613B (en) | 2024-02-02 |
Family
ID=81548929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210093958.4A Active CN114507613B (en) | 2022-01-26 | 2022-01-26 | Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114507613B (en) |
WO (1) | WO2023143136A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114181964B (en) * | 2021-11-02 | 2023-06-09 | 云南大学 | Expression cassette combination, recombinant vector, recombinant saccharomyces cerevisiae and application of recombinant saccharomyces cerevisiae |
CN114507613B (en) * | 2022-01-26 | 2024-02-02 | 浙江大学杭州国际科创中心 | Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160018212A (en) * | 2014-08-08 | 2016-02-17 | 경상대학교산학협력단 | METHOD OF PRODUCING α-SANTALENE |
CN111434773A (en) * | 2019-01-15 | 2020-07-21 | 天津大学 | Recombinant yeast for high-yield sandalwood oil and construction method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2252691B1 (en) * | 2008-03-06 | 2013-03-27 | Firmenich S.A. | Method for producing alpha- santalene |
CN104039973B (en) * | 2012-01-06 | 2017-08-11 | 弗门尼舍有限公司 | Gene engineering yeast cell |
US9714418B2 (en) * | 2014-03-31 | 2017-07-25 | Evolva, Inc. | Modified santalene synthase polypeptides, encoding nucleic acid molecules and uses thereof |
CN112852650B (en) * | 2019-11-27 | 2023-04-14 | 暨南大学 | Saccharomyces cerevisiae engineering bacterium for high yield of santalene and santalol and construction method and application thereof |
CN111235046A (en) * | 2020-02-05 | 2020-06-05 | 天津大学 | Recombinant yarrowia lipolytica for heterologous synthesis of α -santalene and construction method thereof |
CN114507613B (en) * | 2022-01-26 | 2024-02-02 | 浙江大学杭州国际科创中心 | Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof |
-
2022
- 2022-01-26 CN CN202210093958.4A patent/CN114507613B/en active Active
-
2023
- 2023-01-13 WO PCT/CN2023/072128 patent/WO2023143136A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160018212A (en) * | 2014-08-08 | 2016-02-17 | 경상대학교산학협력단 | METHOD OF PRODUCING α-SANTALENE |
CN111434773A (en) * | 2019-01-15 | 2020-07-21 | 天津大学 | Recombinant yeast for high-yield sandalwood oil and construction method and application thereof |
Non-Patent Citations (1)
Title |
---|
Establishing a platform cellfactory through engineering of yeast acetyl-CoA metabolism;Yun Chen等;Metabolic Engineering;第51页图2 * |
Also Published As
Publication number | Publication date |
---|---|
CN114507613A (en) | 2022-05-17 |
WO2023143136A1 (en) | 2023-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114507613B (en) | Yeast engineering bacteria for producing alpha-santalene by fermentation and application thereof | |
CN108753636A (en) | A kind of yeast and construction method producing tyrosol and hydroxytyrosol | |
CN107815424B (en) | Yarrowia lipolytica gene engineering bacterium for producing limonene and application thereof | |
CN113234610B (en) | Saccharomyces cerevisiae strain for synthesizing squalene and application thereof | |
CN112159769B (en) | Genetically engineered bacterium for producing L-menthol and construction method and application thereof | |
CN105420135A (en) | Recombined saccharomyces cerevisiae bacterial strain of high-yield monoterpene geraniol and application of recombined saccharomyces cerevisiae bacterial strain | |
CN113832044A (en) | Recombinant yarrowia lipolytica, construction method and application thereof | |
CN111088175A (en) | Yarrowia lipolytica for producing bisabolene and construction method and application thereof | |
CN113604472B (en) | CRISPR/Cas gene editing system applied to Trichoderma reesei | |
CN105368732A (en) | Industrial saccharomyces cerevisiae strain capable of producing xylitol and construction method of industrial saccharomyces cerevisiae strain | |
CN107365715A (en) | A kind of preparation method and application of the Candida glycerolgenesis engineering bacteria of the benzyl carbinol of high yield 2 | |
CN116042425A (en) | Yeast engineering bacteria for producing patchouli alcohol and application thereof | |
CN111334459B (en) | Construction method and application of Klebsiella engineering bacteria for improving yield of 1, 3-propylene glycol | |
CN110004099A (en) | A kind of fermentation method for producing of rhodioside | |
CN111378587B (en) | Genetically engineered bacterium for synthesizing beta-farnesene and application thereof | |
CN114606146B (en) | Yeast for producing D-limonene and application thereof | |
CN108384798A (en) | A method of utilizing Agrobacterium tumefaciens transformation Mortierella alpina mycelia | |
CN112501043B (en) | Saccharomyces cerevisiae engineering bacterium for producing geranylgeraniol and construction method and application thereof | |
CN111909862B (en) | Genetically engineered bacterium for high yield of 2-phenethyl alcohol and application thereof | |
CN118360174A (en) | Production method of orcinol glucoside | |
CN118272453A (en) | Recombinant yeast and method for producing beta-myrcene | |
CN116515655A (en) | Yeast engineering bacteria for producing beta-elemene and application thereof | |
CN117844837A (en) | Construction method and application of succinic acid-producing escherichia coli genetically engineered bacterium | |
CN115927500A (en) | Method for preparing scopoletin lactone by enzyme method | |
CN116103175A (en) | Yeast engineering bacteria for producing triacetic acid lactone by fermentation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |